Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)

NCT07260734 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07260734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
November 1, 2028
Enrollment
6,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breath tests, gastric adenocarcinoma and gastroesophageal junction adenocarcinoma, oesophageal adenocarcinoma, oesophageal cancer, oesophageal cancer nos, oesophageal junction cancer, oesophago-gastric carcinoma, volatile organic compound